REDWOOD CITY, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced that Randy Scott, Ph.D., the Company’s Chairman and Chief Executive Officer, will present at the 24th Annual JPMorgan Healthcare Conference on Monday, January 9, 2006 at 3:30 PM Pacific (6:30 PM Eastern) at the Westin St. Francis in San Francisco.
To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of the Company’s website at http://investor.genomichealth.com . Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary. An archived replay will be available for three months beginning 24 hours after the live presentation. Please log on at least 15 minutes in advance to allow for any necessary software downloads.
About Genomic Health
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.
Genomic Health, Inc.
CONTACT: Brad Cole of Genomic Health, Inc., +1-650-569-2281, orinvestors@genomichealth.com, or media, Emily Faucette of WeissCommPartners, +1-415-946-1066, or media@genomichealth.com
Web site: http://www.genomichealth.com/
